PerkinElmer Receives Commercial Approval From the Central Drugs Standard Control Organization, India for Its SARS-CoV-2 Real-Time RT-PCR Assay
|
|
|
|
|
|
|
|
|
|
Date: 10-06-2020 10:50AM Source: PerkinElmer (India) Pvt Ltd Category: General, Consumer Interest, Science & Research, Healthcare & Biotechnology, Pharmaceutical Location: New Delhi, Delhi, India
Business Wire India
| PerkinElmer® New Coronavirus Nucleic Acid Detection Kit |
PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced that PerkinElmer India has received commercial approval by the Central Drugs Standard Control Organization (CDSCO) for the PerkinElmer New Coronavirus Nucleic Acid Detection Kit. This test is intended to help meet the heightened needs for COVID-19 testing in India.
PerkinElmer’s RT-PCR test received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA). It is also marketed as an in vitro diagnostic (IVD) device by meeting the requirements of the European In Vitro Diagnostic Directive (IVDD) and is now available in over 30 countries worldwide.
“COVID-19 continues to have a significant impact in India and it is imperative that testing facilities have the kits on hand to identify cases without delay. Receiving CDSCO approval for our RT-PCR test will bolster the solutions available to testing facilities across India and help toward improving health outcomes,” said Shripad Joshi, Director, India and South Asia, PerkinElmer.
“Early detection is crucial to help control the spread of COVID-19 in the world’s second-largest population, and the commercial approval for this new kit strengthens India’s testing capabilities in order to more effectively address this pandemic,” said Serge Moubarak, Managing Director, India, South Asia & Emerging Markets, PerkinElmer.About PerkinElmer
PerkinElmer enables scientists, researchers, and clinicians to address their most critical challenges across science and healthcare. With a mission focused on innovating for a healthier world, we deliver unique solutions to serve the diagnostics, life sciences, food, and applied markets. We strategically partner with customers to enable earlier and more accurate insights supported by deep market knowledge and technical expertise. Our dedicated team of about 13,000 employees worldwide is passionate about helping customers work to create healthier families, improve the quality of life, and sustain the wellbeing and longevity of people globally. The Company reported revenue of approximately $2.9 billion in 2019, serves customers in 190 countries, and is a component of the S&P 500 index. Additional information is available through 1-877-PKI-NYSE, or at www.perkinelmer.com.
About PerkinElmer in India
With a mission focused on innovating for a healthier world, PerkinElmer enables scientists, researchers, and clinicians to address their most critical challenges in science and health by offering unique instruments, informatics and service solutions for advanced testing and analysis. Since 1981, PerkinElmer has worked with customers in India, spanning a wide range of markets including pharmaceutical, food, life science, diagnostics, and applied markets. PerkinElmer established direct operations in India in 2004 and currently has more than 10,000 customers and over 550 employees in India and South Asia. Additional information is available at www.perkinelmer.com.
|
More Press Releases C3.ai Digital Transformation Institute Announces AI for Energy and Climate Security Grantees Moody’s Launches Moody’s Moments Video Series Providing Insight into Corporate Strategy IDEMIA Signs With Storstockholms Lokaltrafik “SL” to Launch the World’s First Ever Public Transport EMV White Label Cards Celebrity Face: India's No.1 Platform for Aspiring Content Creators and Fans to Photoshoot with Top Celebrities Tally Solutions Announces the First Edition of MSME Honours Sourced from the Himalayan Regions, Moving to the Wonders of Australia - BOHECO Joins Hands with Spring Sciences Australia Moneycontrol App's Monthly Active Users Six Times Larger Than Its Closest Competitor for May 2021 - Similarweb Healthcare Cloud Unicorn, Innovaccer, Certified as a Great Place to Work® Company The Nation Gears up for the First-ever Edition of National Poker Series, India DXC Technology Welcomes Brenda Tsai as Chief Marketing and Communications Officer Schlumberger New Energy and Panasonic Energy of North America Announce Strategic Collaboration on New Battery-Grade Lithium Production Process Fashion Designer Sanjukta Dutta Contributes Towards the Vaccination Drive Held in Assam Under the Guidance of Honorable Chief Minister Dr. Hemanta Biswa Sarma Western Union Accelerates Digital Money Movement for Postal Networks Worldwide NMIMS School of Branding and Advertising Partners with 120 Media Collective and Advertising Standards Council of India High-Touch Spectacles Now Made Virus Free by ZEISS DuraVision AntiVirus Platinum UV IRM India Affiliate Announces Results for May 2021 Level-1 Examination Wipro Annual Report 2021 on Form 20-F Available Online for ADS Holders RSA Introduces Outseer, a Spinout of its Fraud & Risk Intelligence Unit, to Transform Customer Authentication and Accelerate Revenue for the Digital Economy Abu Dhabi Based Tablez to Expand Upon Investment in India’s Toys Sector With Its Proprietary Brand
|